XJPX3391
Market cap2.48bUSD
Dec 25, Last price
8,007.00JPY
1D
-0.48%
1Q
-12.41%
Jan 2017
-27.86%
IPO
215.24%
Name
Tsuruha Holdings Inc
Chart & Performance
Profile
Tsuruha Holdings Inc. operates drugstores in Japan. It sells pharmaceutical and cosmetic products. As of October 15, 2021, the company operated 2,448 stores in Japan and 22 stores in Thailand. The company was founded in 1929 and is headquartered in Sapporo, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑05 | 2023‑05 | 2022‑05 | 2021‑05 | 2020‑05 | 2019‑05 | 2018‑05 | 2017‑05 | 2016‑05 | 2015‑05 | |
Income | ||||||||||
Revenues | 1,027,462,000 5.92% | 970,079,000 5.94% | 915,700,000 -0.39% | |||||||
Cost of revenue | 715,185,000 | 676,717,000 | 644,217,000 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 312,277,000 | 293,362,000 | 271,483,000 | |||||||
NOPBT Margin | 30.39% | 30.24% | 29.65% | |||||||
Operating Taxes | 14,733,000 | 14,812,000 | 13,234,000 | |||||||
Tax Rate | 4.72% | 5.05% | 4.87% | |||||||
NOPAT | 297,544,000 | 278,550,000 | 258,249,000 | |||||||
Net income | 24,105,000 -4.56% | 25,258,000 18.09% | 21,388,000 -18.62% | |||||||
Dividends | (13,465,000) | (9,716,000) | (8,106,000) | |||||||
Dividend yield | 2.96% | 2.07% | 2.36% | |||||||
Proceeds from repurchase of equity | (2,088,000) | 18,374,000 | ||||||||
BB yield | 0.44% | -5.36% | ||||||||
Debt | ||||||||||
Debt current | 8,637,000 | 11,403,000 | 7,751,000 | |||||||
Long-term debt | 59,166,000 | 58,848,000 | 56,614,000 | |||||||
Deferred revenue | 7,000 | 7,182,000 | 7,966,000 | |||||||
Other long-term liabilities | 11,915,000 | 4,476,000 | 3,767,000 | |||||||
Net debt | (25,066,000) | (113,297,000) | (160,528,000) | |||||||
Cash flow | ||||||||||
Cash from operating activities | 51,964,000 | 804,000 | 35,832,000 | |||||||
CAPEX | (31,992,000) | (26,686,000) | (23,058,000) | |||||||
Cash from investing activities | (36,068,000) | (29,774,000) | (28,405,000) | |||||||
Cash from financing activities | (36,259,000) | (19,005,000) | 3,067,000 | |||||||
FCF | 267,581,000 | 217,903,000 | 244,000,000 | |||||||
Balance | ||||||||||
Cash | 58,688,000 | 79,050,000 | 127,026,000 | |||||||
Long term investments | 34,181,000 | 104,498,000 | 97,867,000 | |||||||
Excess cash | 41,495,900 | 135,044,050 | 179,108,000 | |||||||
Stockholders' equity | 291,604,000 | 536,831,000 | 501,080,000 | |||||||
Invested Capital | 328,198,100 | 226,351,950 | 166,911,000 | |||||||
ROIC | 107.31% | 141.66% | 167.46% | |||||||
ROCE | 82.91% | 79.79% | 77.30% | |||||||
EV | ||||||||||
Common stock shares outstanding | 48,848 | 48,714 | 48,700 | |||||||
Price | 9,302.00 -3.51% | 9,640.00 36.93% | 7,040.00 -47.07% | |||||||
Market cap | 454,382,645 -3.24% | 469,598,381 36.97% | 342,845,219 -47.05% | |||||||
EV | 453,115,645 | 638,961,381 | 447,156,219 | |||||||
EBITDA | 330,277,000 | 309,917,000 | 286,146,000 | |||||||
EV/EBITDA | 1.37 | 2.06 | 1.56 | |||||||
Interest | 1,553,000 | 1,301,000 | 802,000 | |||||||
Interest/NOPBT | 0.50% | 0.44% | 0.30% |